Obupro (Oxybuprocaine Hydrochloride)

Oxybuprocaine Hydrochloride, the active ingredient in Obupro, is a local anesthetic presented as a sterile ophthalmic solution for ocular use. It provides rapid surface anesthesia for diagnostic eye examinations and minor ocular procedures. GNH USA supplies Obupro as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Obupro, a topical ophthalmic anesthetic, is employed to achieve temporary corneal numbness for various eye examinations and procedures. - Tonometry: provides rapid corneal anesthesia to facilitate accurate intraocular pressure measurement. - Slit‑lamp examination: enables comfortable evaluation of the anterior segment without patient discomfort. - Minor ocular surgery: supplies short‑acting anesthesia for procedures such as foreign‑body removal or laser treatment.

Obupro may cause a range of ocular reactions, most of which are mild and transient.

Common Side Effects: - Stinging or burning sensation upon instillation. - Temporary blurred vision. - Mild conjunctival redness. - Tearing or lacrimation. - Foreign‑body sensation. - Mild corneal epithelial irritation.

Serious or Rare Side Effects: - Allergic reactions such as contact dermatitis or urticaria. - Corneal ulceration or persistent epithelial defect. - Severe ocular inflammation or keratitis. - Anaphylaxis (rare). - Systemic toxicity from excessive absorption. - Vision loss (extremely rare).

Before using Obupro, consider the following safety measures. - Allergy assessment: verify no hypersensitivity to ester‑type anesthetics. - Corneal integrity: avoid application on damaged or infected epithelium. - Pregnancy: safety not established; use only if potential benefit justifies the risk. - Contact lens wearers: remove lenses prior to instillation and wait before reinserting. - Duration of use: limit to the minimal amount required for the procedure. - Store at room temperature: keep in original container, protect from light and moisture.

Obupro may interact with other ophthalmic agents, requiring careful management.

Major Interactions (Avoid): - Concurrent use with other topical ocular anesthetics: may increase risk of corneal toxicity. - Use with systemic sodium channel blockers: potential additive effect on nerve conduction.

Moderate Interactions (Monitor Closely): - Co‑administration with topical antibiotics: monitor for increased irritation. - Combination with anti‑inflammatory eye drops: assess for altered healing response. - Use with beta‑blocker eye drops: observe for possible changes in intraocular pressure control.